MEI PHARMA INC filings

All
Holdings
Significant ownership
Insider transactions
Annual reports
Quarterly reports
Events
Shareholder votes
SEC filings by MEI PHARMA INC (ownership)
TypeFiledFilerSubjectShares OwnedPercent Owned
SC 13G/A2024-02-14TANG CAPITAL PARTNERS LPMEI Pharma, Inc.326,0844.9%EDGAR
SC 13G/A2024-02-13VANGUARD GROUP INCMEI Pharma, Inc.389,8075.8%EDGAR
SC 13D/A2023-11-01Anson Funds Management LPMEI Pharma, Inc.611,4409.2%EDGAR
SC 13D/A2023-10-24Anson Funds Management LPMEI Pharma, Inc.611,4409.2%EDGAR
SC 13D/A2023-10-13Anson Funds Management LPMEI Pharma, Inc.490,8407.4%EDGAR
SC 13D/A2023-09-26Anson Funds Management LPMEI Pharma, Inc.460,8406.9%EDGAR
SC 13D/A2023-09-22Anson Funds Management LPMEI Pharma, Inc.428,8006.4%EDGAR
SC 13D/A2023-09-15Anson Funds Management LPMEI Pharma, Inc.326,4004.9%EDGAR
SC 13D/A2023-08-08Anson Funds Management LPMEI Pharma, Inc.326,4004.9%EDGAR
SC 13D/A2023-07-17Anson Funds Management LPMEI Pharma, Inc.326,4004.9%EDGAR
SC 13D2023-05-30Anson Funds Management LPMEI Pharma, Inc.326,4004.9%EDGAR
SC 13G2023-05-01TANG CAPITAL PARTNERS LPMEI Pharma, Inc.361,0845.4%EDGAR
SC 13D/A2023-03-09Growth Equity Opportunities V, LLCMEI Pharma, Inc.--EDGAR
SC 13G2023-02-14Anson Funds Management LPMEI Pharma, Inc.10,617,9598.0%EDGAR
SC 13G/A2023-02-09UBS Oncology Impact Fund L.P.MEI Pharma, Inc.00.0%EDGAR
SC 13G2023-02-09VANGUARD GROUP INCMEI Pharma, Inc.7,671,0245.8%EDGAR
SC 13G/A2022-05-31First Light Asset Management, LLCMEI Pharma, Inc.00.0%EDGAR
SC 13G/A2022-04-07WASATCH ADVISORS INCMEI Pharma, Inc.--EDGAR
SC 13G/A2022-02-14First Light Asset Management, LLCMEI Pharma, Inc.11,577,7128.7%EDGAR
SC 13G2022-02-11WASATCH ADVISORS INCMEI Pharma, Inc.--EDGAR
External links